Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of VISTA PHARMA. For more details, see the VISTA PHARMA quarterly results and VISTA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 4.8 |
No. of shares | m | 47.56 |
1 Week | % | 5.8 |
1 Month | % | 16.8 |
1 Year | % | 41.3 |
52 week H/L | Rs | 19.7/8.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VISTA PHARMA EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 44 | 21 | 16 | 18 | 14 | |
Low | Rs | 18 | 5 | 5 | 7 | 7 | |
Sales per share (Unadj.) | Rs | 10.2 | 7.5 | 0.3 | 0.1 | 0.3 | |
Earnings per share (Unadj.) | Rs | 0.3 | -1.2 | -0.5 | -0.2 | -1.5 | |
Diluted earnings per share | Rs | 0.2 | -0.8 | -0.4 | -0.2 | -1.2 | |
Cash flow per share (Unadj.) | Rs | 0.8 | -0.8 | -0.3 | -0.1 | -1.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 11.0 | 9.8 | 8.9 | 9.6 | 8.1 | |
Adj. book value per share | Rs | 7.0 | 6.2 | 6.9 | 7.5 | 6.4 | |
Shares outstanding (eoy) | m | 30.37 | 30.37 | 36.79 | 36.79 | 37.56 | |
Price / Sales ratio | x | 3.1 | 1.7 | 30.3 | 116.4 | 39.1 | |
Avg P/E ratio | x | 101.6 | -10.4 | -19.1 | -51.7 | -6.9 | |
P/CF ratio (eoy) | x | 41.4 | -16.4 | -30.0 | -168.6 | -7.8 | |
Price / Book Value ratio | x | 2.9 | 1.3 | 1.2 | 1.3 | 1.3 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 954 | 383 | 384 | 459 | 393 | |
Total wages/salary | Rs m | 12 | 13 | 12 | 6 | 5 |
VISTA PHARMA INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 311 | 228 | 13 | 4 | 10 | |
Other income | Rs m | 29 | 37 | 2 | 2 | 4 | |
Total revenues | Rs m | 340 | 265 | 15 | 6 | 14 | |
Gross profit | Rs m | 12 | -48 | -17 | -13 | -44 | |
Depreciation | Rs m | 14 | 13 | 7 | 6 | 6 | |
Interest | Rs m | 17 | 15 | 15 | 9 | 12 | |
Profit before tax | Rs m | 11 | -39 | -38 | -26 | -59 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2 | -3 | -18 | -17 | -2 | |
Profit after tax | Rs m | 9 | -37 | -20 | -9 | -57 | |
Gross profit margin | % | 4.0 | -21.1 | -136.6 | -320.8 | -442.7 | |
Effective tax rate | % | 18.1 | 6.6 | 47.3 | 66.0 | 3.6 | |
Net profit margin | % | 3.0 | -16.2 | -158.7 | -225.0 | -563.9 |
VISTA PHARMA BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 234 | 212 | 152 | 236 | 238 | |
Current liabilities | Rs m | 109 | 159 | 92 | 126 | 141 | |
Net working cap to sales | % | 40.2 | 23.1 | 473.2 | 2,765.3 | 963.0 | |
Current ratio | x | 2.1 | 1.3 | 1.6 | 1.9 | 1.7 | |
Inventory Days | Days | 1 | 2 | 2,409 | 121 | 207 | |
Debtors Days | Days | 980 | 1,649 | 6,254 | 96,693 | 40,902 | |
Net fixed assets | Rs m | 292 | 296 | 374 | 285 | 296 | |
Share capital | Rs m | 61 | 61 | 74 | 74 | 75 | |
"Free" reserves | Rs m | 272 | 236 | 255 | 281 | 230 | |
Net worth | Rs m | 333 | 296 | 328 | 355 | 306 | |
Long term debt | Rs m | 60 | 55 | 87 | 74 | 52 | |
Total assets | Rs m | 526 | 507 | 526 | 521 | 534 | |
Interest coverage | x | 1.7 | -1.6 | -1.5 | -1.9 | -3.8 | |
Debt to equity ratio | x | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | |
Sales to assets ratio | x | 0.6 | 0.4 | 0 | 0 | 0 | |
Return on assets | % | 5.0 | -4.2 | -0.9 | 0 | -8.3 | |
Return on equity | % | 2.8 | -12.4 | -6.1 | -2.5 | -18.5 | |
Return on capital | % | 7.2 | -6.8 | -5.4 | -4.0 | -13.1 | |
Exports to sales | % | 21.4 | 18.5 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 67 | 42 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 68 | 44 | 1 | 0 | 0 | |
Fx outflow | Rs m | 1 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 67 | 44 | 1 | 0 | 0 |
VISTA PHARMA CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 33 | 8 | -67 | -10 | -17 | |
From Investments | Rs m | -56 | -17 | -3 | -0 | -13 | |
From Financial Activity | Rs m | 14 | 3 | 70 | 9 | 31 | |
Net Cashflow | Rs m | -9 | -6 | -1 | -1 | 1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Dhananjaya Alli | COMP SEC: Akash Bhagadia | YEAR OF INC: 1991 | BSE CODE: 524711 | FV (Rs): 2 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare VISTA PHARMA With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Indian share markets continued the momentum as the session progressed and ended the higher.